I like the fact this interview states from Tony himself that there will be a lack of dilution to CFE. So it's likely there won't be a capital raising. IMO
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025